The Path Beyond COVID-19: Management of Kidney Transplant Patients Using TruGraf® for Surveillance

TruGraf is the only blood test validated and reimbursed to rule out “silent” subclinical rejection in patients with stable renal function! Learn how top thought leaders in kidney transplatation are using TruGraf for kidney care protocols and the long-term outcomes.

Listed below are all the speakers:

Overview of TruGraf - John Friedewald, MD,
Medical Director, Kidney and Pancreas Transplantation

Avoiding Surveillance Biopsies: Role of TruGraf - Clifton Kew II, MD,
Medical Director, Kidney and Pancreas Transplant Program

Monitoring Renal Allograft Function in the Age of COVID-19 - Ethan Marin, MD, PhD,
Assistant Professor, Section of Nephrology

Using TruGraf as Surveillance During COVID-19 - Michael J. Germain, MD,
Medical Director, Renal Transplantation and Associate Professor of Medicine

Real Life use of TruGraf vs cfDNA - Neeraj Singh, MD, FASN, FASH,
Medical Director, Kidney and Pancreas Transplantation